Clinical Trial Management: Cutting Clinical Trial Costs
Paper 2 of the Clinical Trial Management series
With drug development costs doubling in the last 20 years, any sort of delay in clinical trials can be costly. Adding one month to a phase III trial adds an average of over $670,000 to the total cost. This whitepaper breaks down the costs associated with clinical trials and proposes solutions to reduce spend across all phases.
What you’ll learn:
- Why clinical trial costs are increasing
- Breakdown of expenses by phase and therapeutic area
- How to reduce overall trial costs
To learn more, fill out the form to download our whitepaper today!